Physician
Cincinnati Pain Physicians LLC
Cincinnati Pain Physicians LLC was paid $363K by Medicaid between Jan 2018 and Nov 2024, across 35 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 54% of everything it billed.
33Billing provider infoCINCINNATI PAIN PHYSICIANS LLC
CINCINNATI, OH 45249
CINCINNATI, OH 45249
33aNPI1457790941assigned 06/18/2013
33bProvider typePain Medicine Physician
28Total paid$363K
24GClaims17,934
24DCodes billed35
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Pain Medicine Physician providers in Ohio
Rank by total paid#5 of 16
Median peer was paid$112K
This provider vs. median3.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,246 | $41K | |
| 2019 | 2,682 | $57K | |
| 2020 | 3,620 | $71K | |
| 2021 | 2,539 | $55K | |
| 2022 | 3,110 | $71K | |
| 2023 | 1,750 | $40K | |
| 2024incomplete | 987 | $28K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 54% | 8,880 | 7,674 | $197K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 33% | 3,480 | 3,123 | $121K |
| 99442 | 3.0% | 1,107 | 893 | $11K | |
| 99152 | 1.8% | 446 | 387 | $7K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.5% | 360 | 313 | $6K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.5% | 99 | 78 | $6K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 154 | 127 | $3K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 162 | 135 | $2K |
| 62370 | <1% | 76 | 65 | $2K | |
| 76942 | <1% | 78 | 66 | $2K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 225 | 197 | $1K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 14 | 12 | $1K |
23 more codes
| 20611 | <1% | 17 | $902.90 | |
| 62323 | <1% | 21 | $660.67 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 588 | $398.69 |
| 80346 | <1% | 68 | $290.03 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 395 | $276.69 |
| 80361 | <1% | 68 | $248.43 | |
| 80372 | <1% | 68 | $212.18 | |
| 80369 | <1% | 68 | $212.18 | |
| 80373 | <1% | 68 | $212.18 | |
| 80348 | <1% | 68 | $203.27 | |
| 80365 | <1% | 67 | $203.27 | |
| 80354 | <1% | 68 | $203.27 | |
| 83992 | <1% | 13 | $196.69 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 62 | $188.87 |
| 80324 | <1% | 68 | $137.93 | |
| 80358 | <1% | 68 | $137.93 | |
| 80353 | <1% | 68 | $137.93 | |
| 80356 | <1% | 68 | $137.93 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 210 | $100.76 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 500 | $87.36 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 12 | $34.92 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 36 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 184 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSUDARSHAN, GURURAU (MD/CEO)